- Home
- RLMD vs SWZ Comparison
RLMD vs SWZ Comparison
Compare RLMD & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- SWZ
- Stock Information
- Founded
- RLMD 2004
- SWZ 1986
- Country
- RLMD United States
- SWZ United States
- Employees
- RLMD N/A
- SWZ N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- SWZ Finance Companies
- Sector
- RLMD Health Care
- SWZ Finance
- Exchange
- RLMD Nasdaq
- SWZ Nasdaq
- Market Cap
- RLMD 66.7M
- SWZ 78.7M
- IPO Year
- RLMD N/A
- SWZ N/A
- Fundamental
- Price
- RLMD $1.99
- SWZ $6.00
- Analyst Decision
- RLMD Hold
- SWZ
- Analyst Count
- RLMD 2
- SWZ 0
- Target Price
- RLMD $1.00
- SWZ N/A
- AVG Volume (30 Days)
- RLMD 517.7K
- SWZ 14.2K
- Earning Date
- RLMD 11-06-2025
- SWZ 01-01-0001
- Dividend Yield
- RLMD N/A
- SWZ 6.59%
- EPS Growth
- RLMD N/A
- SWZ N/A
- EPS
- RLMD N/A
- SWZ N/A
- Revenue
- RLMD N/A
- SWZ N/A
- Revenue This Year
- RLMD N/A
- SWZ N/A
- Revenue Next Year
- RLMD N/A
- SWZ N/A
- P/E Ratio
- RLMD N/A
- SWZ N/A
- Revenue Growth
- RLMD N/A
- SWZ N/A
- 52 Week Low
- RLMD $0.24
- SWZ $7.12
- 52 Week High
- RLMD $3.98
- SWZ $8.57
- Technical
- Relative Strength Index (RSI)
- RLMD 59.73
- SWZ 35.18
- Support Level
- RLMD $1.89
- SWZ $6.04
- Resistance Level
- RLMD $2.84
- SWZ $6.11
- Average True Range (ATR)
- RLMD 0.28
- SWZ 0.04
- MACD
- RLMD 0.01
- SWZ -0.01
- Stochastic Oscillator
- RLMD 37.96
- SWZ 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.